Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
Year: 2022
Type: article
Source: Nature Reviews Drug Discovery
Institutions: Cancer Research Institute, IQVIA (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4211168024
